Pharming Execs to Present at Two High-Profile Investor Conferences…

Event summary

Pharming Group N.V. will participate in two investor conferences in September 2026.
CEO Fabrice Chouraqui will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026.
The company will also attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026.
Live webcasts and replays of the presentations will be available on Pharming’s website.

The big picture

Pharming’s participation in these high-profile investor conferences underscores its focus on engaging with the financial community amid a competitive biopharmaceutical landscape. The events provide a platform for the company to articulate its strategic vision and address investor concerns, particularly as it navigates the challenges of developing and commercializing treatments for rare diseases. The scale of these conferences, attended by key industry players, will amplify Pharming’s visibility and potentially attract new investment.

What we're watching

Market Perception: How Pharming’s presentations will influence investor sentiment and stock performance.
Strategic Messaging: Whether the company will provide updates on pipeline progress or commercial milestones.
Competitive Positioning: The pace at which Pharming can differentiate itself in the crowded rare disease therapeutics space.